Putative folding pathway of insulin-like growth factor-1

被引:32
|
作者
Rosenfeld, RD
Miller, JA
Narhi, LO
Hawkins, N
Katta, V
Lauren, S
Weiss, MA
Arakawa, T
机构
[1] Amgen Inc., Amgen Center, Thousand Oaks
[2] Amgen Inc., Amgen Center, 14-2-A-223, Thousand Oaks
关键词
D O I
10.1006/abbi.1997.9996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor-1 (IGF-I) has three disulfide bonds and refolding of the fully reduced molecule generates varying ratios of correctly (PII) and incorrectly (PI) folded forms via several intermediates, All of the intermediates have the disulfide bond between Cys18 and 61 formed, indicating that formation of this disulfide is the first step in refolding. In order to further understand the refolding pathway, two intermediate forms, PIII with the additional disulfide Cys(6/47) formed and PIIIa with Cys(6/48) formed, were isolated, The oxidation of the remaining Cys48 and 52 in PIII and Cys47 and 52 in PIIIa would lead to PI and PII, respectively; however, air oxidation of these resulted in a rapid reshuffling into other intermediates as well as folding into the fully oxidized forms, and this occurred whether refolding was started with PIII or PIIIa. When oxidation occurred in the presence of an excess of oxidized glutathione, the predominant species generated were various glutathione adducts regardless of the initial intermediate form, indicating that formation of the last disulfide bond is not a favorable process relative to disulfide exchange when excess disulfides from oxidized glutathione are present. Interestingly, if 80 mu M copper sulfate, an oxidant, is added to the refolding buffer, PIII resulted in formation of the PI form alone, whereas PIIIa resulted in the PII form alone. It was concluded from these results that the intermediate forms of IGF-1 can rapidly reshuffle between different disulfide structures, and that formation of the last disulfide bond is not as favorable a process as the conversion to other intermediates, The oxidation to form the last disulfide bond in PIII or PIIIa is accelerated and hence the interconversion to other intermediates is kinetically minimized only in the presence of copper sulfate. It appears, therefore, that the two intermediate forms, PIII and PIIIa, are the precursors of the corresponding fully oxidized forms, but their conversions are not energetically a favorable process. (C) 1997 Academic Press.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 50 条
  • [31] Insulin-Like Growth Factor-1 in Acute Ischemic Stroke
    Shaheen H.
    Sobhy S.
    El Mously S.
    Niazi M.
    Gomaa M.
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 54 (1)
  • [32] Insulin-like growth factor-1 in CNS and cerebrovascular aging
    Sonntag, William E.
    Deak, Ferenc
    Ashpole, Nicole
    Toth, Peter
    Csiszar, Anna
    Freeman, Willard
    Ungvari, Zoltan
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [33] Insulin-Like Growth Factor-1 and Central Neurodegenerative Diseases
    Torres Aleman, Ignacio
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (02) : 395 - +
  • [34] Research questions concerning insulin-like growth factor-1
    Cradock A.L.
    Cancer Causes & Control, 2000, 11 (1) : 89 - 91
  • [35] Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
    Smith, John Kelly
    APPLIED SCIENCES-BASEL, 2020, 10 (13):
  • [36] Insulin-like growth factor-1 expression in reflux nephropathy
    Boris Chertin
    Amicur Farkas
    Prem Puri
    Pediatric Surgery International, 2004, 20 : 283 - 289
  • [37] Insulin-like growth factor-1 expression in reflux nephropathy
    Chertin, B
    Farkas, A
    Puri, P
    PEDIATRIC SURGERY INTERNATIONAL, 2004, 20 (04) : 283 - 289
  • [38] Diet, insulin-like growth factor-1 and cancer risk
    Key, Timothy J.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2011, 70 (03) : 385 - 388
  • [39] Insulin-like growth factor-1 elevated in hypertensive patients
    Ugalde, A
    Bernal, E
    Sanchez, O
    Fernandez, E
    Monge, B
    Marquez, J
    Fabregate, R
    Calbacho, M
    Saban-Ruiz, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 164A - 164A
  • [40] Role of insulin-like growth factor-1 in postmenopausal osteoporosis
    Muñoz-Torres, M
    Mezquita-Raya, P
    López-Rodríguez, F
    Torres-Vela, E
    Escobar-Jimenez, F
    BONE, 2001, 29 (03) : 306 - 306